A census of anti-CRISPR proteins reveals AcrIE9 and AcrIE13 as inhibitors of the Escherichia coli K12 type IE CRISPR-Cas system

Read full text
Authors: Dmitry Taranenko, Oksana Kotovskaya, Konstantin D. Kuznedelov, Daria Yanovskaya, Alina Demkina, Sofya Fardeeva, Viktor Mamontov, Kaiya Vierra, Nathaniel Burman, Dan Li, Minggui Wang, Blake Wiedenheft
+3 more Konstantin Severinov, Е. А. Семенова, Artem Isaev
Cited by: 1
References: 106

Abstract

CRISPR-Cas adaptive immunity systems provide defense against mobile genetic elements and are often countered by diverse anti-CRISPR (Acr) proteins. The type IE CRISPR-Cas of Escherichia coli K12 has been a model for structural and functional studies and is a part of the species’ core genome. However, this system is transcriptionally silent, which has fueled questions about its true biological function. To clarify the role of this system in defense, we carried out a census of Acr proteins in Enterobacterales and identified AcrIE9 as a potent inhibitor of the E. coli K12 type IE CRISPR-Cas system. While sharing little sequence identity, AcrIE9 proteins from Pseudomonas and Escherichia both interact with the Cas7 subunit of the Cascade complex, thus preventing its binding to DNA. We further show that AcrIE9 is genetically linked to AcrIE10, forming the most widespread anti-CRISPR cluster in Enterobacterales ; this module often co-occurs with an AcrIE13 protein with an unusual HTH-like architecture.

Fields of Study & Subjects

CRISPR and Genetic Engineering Microbial Metabolic Engineering and Bioproduction Vibrio bacteria research studies

Publication details

Journal / source
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Volume
123
Issue
24
Pages
e2529903123–e2529903123
Publication date
8 June 2026
Language
EN